Johnson & Johnson reported quarterly EPS of $2.90, beating the Zacks Consensus Estimate of $2.84 (up $0.13 from $2.77 a year ago). The modest EPS beat suggests slightly better-than-expected fundamentals, with limited likely impact beyond JNJ’s stock.
Johnson & Johnson reported quarterly EPS of $2.90, beating the Zacks Consensus Estimate of $2.84 (up $0.13 from $2.77 a year ago). The modest EPS beat suggests slightly better-than-expected fundamentals, with limited likely impact beyond JNJ’s stock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
